Himax Subsidiary Liqxtal Technology Pro-Eye Vision Care Display Makes its Medical Taiwan 2025 Debut
Himax Technologies (NASDAQ: HIMX) and its subsidiary Liqxtal Technology announced they will showcase their groundbreaking Liqxtal® Pro-Eye vision care display at Medical Taiwan 2025. The display utilizes patented electrically tunable liquid crystal technology to project virtual images at approximately 16 feet away, compared to conventional monitors' 20-24 inch viewing distance.
The technology aims to reduce eye strain and ciliary muscle fatigue, particularly benefiting seniors with presbyopia and helping prevent myopia progression in school-aged children. The company will also present the Liqxtal® Dim adaptive lens, which combines pixelated light valve control with Himax's WiseEye AI sensing technology for smart sunglasses and vision training devices.
Himax Technologies (NASDAQ: HIMX) e la sua controllata Liqxtal Technology hanno annunciato che presenteranno il loro innovativo display per la cura della vista Liqxtal® Pro-Eye al Medical Taiwan 2025. Questo display utilizza una tecnologia brevettata di cristalli liquidi elettricamente regolabili per proiettare immagini virtuali a circa 16 piedi di distanza, rispetto ai tradizionali monitor con una distanza di visione di 20-24 pollici.
La tecnologia è progettata per ridurre l’affaticamento degli occhi e dei muscoli ciliari, offrendo benefici speciali agli anziani con presbiopia e contribuendo a prevenire la progressione della miopia nei bambini in età scolare. L’azienda presenterà anche la lente adattiva Liqxtal® Dim, che combina il controllo a valvola luminosa pixelata con la tecnologia di rilevamento AI WiseEye di Himax per occhiali da sole intelligenti e dispositivi per l’allenamento della vista.
Himax Technologies (NASDAQ: HIMX) y su subsidiaria Liqxtal Technology anunciaron que presentarán su innovadora pantalla Liqxtal® Pro-Eye para el cuidado de la visión en Medical Taiwan 2025. La pantalla utiliza una tecnología patentada de cristal líquido eléctricamente ajustable para proyectar imágenes virtuales a aproximadamente 16 pies de distancia, en comparación con la distancia de visualización de 20-24 pulgadas de los monitores convencionales.
Esta tecnología busca reducir la fatiga ocular y del músculo ciliar, beneficiando especialmente a personas mayores con presbicia y ayudando a prevenir la progresión de la miopía en niños en edad escolar. La compañía también presentará la lente adaptativa Liqxtal® Dim, que combina el control de válvula de luz pixelada con la tecnología de detección AI WiseEye de Himax para gafas inteligentes y dispositivos de entrenamiento visual.
Himax Technologies (NASDAQ: HIMX)와 자회사 Liqxtal Technology가 Medical Taiwan 2025에서 혁신적인 Liqxtal® Pro-Eye 시력 케어 디스플레이를 선보일 예정입니다. 이 디스플레이는 특허받은 전기 조절 가능 액정 기술을 사용하여 기존 모니터의 20-24인치 시청 거리와 달리 약 16피트 거리에서 가상 이미지를 투사합니다.
이 기술은 눈의 피로와 모양체 근육의 피로를 줄이는 것을 목표로 하며, 특히 노안이 있는 노인들에게 유익하고 학령기 아동의 근시 진행을 예방하는 데 도움을 줍니다. 또한 회사는 픽셀화된 광 밸브 제어와 Himax의 WiseEye AI 감지 기술을 결합한 스마트 선글라스 및 시력 훈련 장치용 Liqxtal® Dim 적응형 렌즈도 선보일 예정입니다.
Himax Technologies (NASDAQ : HIMX) et sa filiale Liqxtal Technology ont annoncé qu’elles présenteront leur écran révolutionnaire Liqxtal® Pro-Eye pour le soin de la vision lors du Medical Taiwan 2025. Cet écran utilise une technologie brevetée de cristaux liquides électriquement réglables pour projeter des images virtuelles à environ 16 pieds de distance, contre une distance de visionnage habituelle de 20 à 24 pouces pour les moniteurs classiques.
Cette technologie vise à réduire la fatigue oculaire et musculaire ciliaire, bénéficiant notamment aux personnes âgées atteintes de presbytie et aidant à prévenir la progression de la myopie chez les enfants d’âge scolaire. L’entreprise présentera également la lentille adaptative Liqxtal® Dim, qui combine le contrôle par valve lumineuse pixellisée avec la technologie de détection IA WiseEye de Himax pour des lunettes de soleil intelligentes et des dispositifs d’entraînement visuel.
Himax Technologies (NASDAQ: HIMX) und seine Tochtergesellschaft Liqxtal Technology kündigten an, dass sie ihr bahnbrechendes Liqxtal® Pro-Eye Vision Care Display auf der Medical Taiwan 2025 vorstellen werden. Das Display nutzt eine patentierte elektrisch einstellbare Flüssigkristalltechnologie, um virtuelle Bilder in etwa 16 Fuß Entfernung zu projizieren, im Vergleich zur üblichen Betrachtungsentfernung von 20-24 Zoll bei herkömmlichen Monitoren.
Die Technologie zielt darauf ab, Augenbelastung und Ermüdung des Ziliarmuskels zu reduzieren, was besonders Senioren mit Presbyopie zugutekommt und hilft, die Myopieentwicklung bei Schulkindern zu verhindern. Das Unternehmen wird außerdem die Liqxtal® Dim adaptive Linse vorstellen, die pixelgesteuerte Lichtventilsteuerung mit Himax’ WiseEye KI-Erkennungstechnologie für intelligente Sonnenbrillen und Sehtrainingsgeräte kombiniert.
- Innovative technology addressing growing vision care needs in both elderly and young populations
- Already deployed in multiple engineering projects with leading industry partners
- Potential applications in presbyopia and myopia markets
- Integration of proprietary technologies from both Himax and Liqxtal showing synergistic capabilities
- None.
Patented Electrically Tunable Liquid Crystal-Based Optical Technologies Ensures Comfortable Viewing Distance Opening a New Chapter in Vision Wellness
TAINAN, Taiwan, May 29, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Liqxtal Technology Inc. (“Liqxtal”), a subsidiary of Himax dedicated to developing various liquid crystal optical components with exceptional design expertise, today jointly unveiled the industry’s first patented vision care display — the Liqxtal® Pro-Eye will be showcased at Medical Taiwan 2025, the premier medical and healthcare technology exhibition in the Asia-Pacific region taking place June 5 – 7 at the Taipei Nangang Exhibition Center, Hall 2. Liqxtal® Pro-Eye has already been deployed in multiple engineering projects with leading industry partners targeting applications addressing age-related presbyopia and slowing the progression of myopia for school-aged children, as well as eye comfort during extended viewing times. Alongside the Pro-Eye display, several other products will also be on display that integrate cutting-edge imaging and liquid crystal-based smart optical technologies.
Liqxtal® Pro-Eye employs patented electrically tunable liquid crystal technology to break beyond the typical 20 to 24-inch viewing distance of conventional computer monitors, projecting a virtual image roughly 16 feet away. This effectively relieves ciliary muscle fatigue, dramatically alleviating eye strain and creating a comfortable, low-effort virtual viewing distance, redefining the interactive experience of personalized displays. Liqxtal’s patented technology is especially suited for seniors and school-age children. It not only eases near-vision strain and eye dryness for individuals with presbyopia but also reduces the risk of axial elongation in children from prolonged close-range reading, thereby helping to delay myopia progression and support vision health.
Liqxtal® Pro-Eye – Cutting-Edge Patented Vision Care Display
Dr. Hung Shan Chen, President of Liqxtal, will give a speech entitled “Presbyopia Savior! The Most Comfortable Vision-Care Display for Seniors,” on June 7 at 1:30 p.m. at the main stage where he will dive into the core technologies behind the Liqxtal® Pro-Eye and its revolutionary application scenarios.
Liqxtal will also showcase a range of other products that combine innovative imaging and smart optical technologies. Among them is the Liqxtal® Dim adaptive lens, which integrates Liqxtal’s exclusive pixelated light valve control with Himax’s WiseEye ultralow power AI sensing technology. Liqxtal® Dim can detect ambient light in real time and adaptively adjust light tuning, making it ideal for smart sunglasses and vision training devices, significantly improving user comfort in both bright sunlight and dim indoor conditions.
“Liqxtal has been relentlessly advancing liquid crystal-based optical technologies and expanding applications particularly in display and wearable applications. The Pro-Eye display showcased at Medical Taiwan is a prime example,” said Dr. Hung Shan Chen, President of Liqxtal. “With our patented electrically tunable liquid crystal technology, Pro-Eye significantly alleviates the fatigue and dryness associated with extended viewing, delivering unprecedented comfort and visual clarity. Whether for seniors, schoolchildren, or anyone who spends long hours in front of a screen, this truly is a tangible innovation in visual wellness for our digital age.”
Himax and Liqxtal warmly invite all interested media and professionals to visit Booth P0430 in the “Digital Health Pavilion” first floor of Hall 2 at the Taipei Nangang Exhibition Center. Come experience the Liqxtal® Pro-Eye display and other cutting-edge technologies firsthand and see how liquid crystal-based optics is transforming health-focused display applications.
About Liqxtal Technology Inc.
Liqxtal Technology Inc. is a Taiwan based company that has been focused on exploring opportunities with liquid crystal (“LC”) beyond just displays since the company’s inception. With a distinguished track record in liquid crystal optics, Liqxtal has developed liquid crystal based optical components such as LC lens for ophthalmic application, LC diffuser for 3D sensing and LC retarder for light sensing. Additionally, Liqxtal designed and released LQ001, a high voltage & tunable frequency LC driver with a 1mm x 2mm footprint, which is particularly ideal for portable products. As a subsidiary of Himax Technologies, Liqxtal also integrates novel display solutions such as tunable backlight with local dimming capability powered by FPGA for niche applications. Lastly, Liqxtal is dedicated to novel vision eyewear technology and strives to innovate and advance useful optical solutions to the world.
About Himax Technologies, Inc.
Himax Technologies, Inc. (NASDAQ: HIMX) is a leading global fabless semiconductor solution provider dedicated to display imaging processing technologies. The Company’s display driver ICs and timing controllers have been adopted at scale across multiple industries worldwide including TVs, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, among others. As the global market share leader in automotive display technology, the Company offers innovative and comprehensive automotive IC solutions, including traditional driver ICs, advanced in-cell Touch and Display Driver Integration (TDDI), local dimming timing controllers (Local Dimming Tcon), Large Touch and Display Driver Integration (LTDI) and OLED display technologies. Himax is also a pioneer in tinyML visual-AI and optical technology related fields. The Company’s industry-leading WiseEyeTM Ultralow Power AI Sensing technology which incorporates Himax proprietary ultralow power AI processor, always-on CMOS image sensor, and CNN-based AI algorithm has been widely deployed in consumer electronics and AIoT related applications. Himax optics technologies, such as diffractive wafer level optics, LCoS microdisplays and 3D sensing solutions, are critical for facilitating emerging AR/VR/metaverse technologies. Additionally, Himax designs and provides touch controllers, OLED ICs, LED ICs, EPD ICs, power management ICs, and CMOS image sensors for diverse display application coverage. Founded in 2001 and headquartered in Tainan, Taiwan, Himax currently employs around 2,200 people from three Taiwan-based offices in Tainan, Hsinchu and Taipei and country offices in China, Korea, Japan, Germany, and the US. Himax has 2,603 patents granted and 389 patents pending approval worldwide as of March 31, 2025.
Forward Looking Statements
Factors that could cause actual events or results to differ materially from those described in this conference call include, but are not limited to, the effect of the Covid-19 pandemic on the Company’s business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortage in supply of key components; changes in environmental laws and regulations; changes in export license regulated by Export Administration Regulations (EAR); exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory and other risks described from time to time in the Company's SEC filings, including those risks identified in the section entitled "Risk Factors" in its Form 20-F for the year ended December 31, 2024 filed with the SEC, as may be amended.
Liqxtal Contact:
Henry Hung, Deputy Director of Market & Sales Division
Liqxtal Technology Inc.
Tel: +886-6-505-0880
Email: info@liqxtal.com
Himax Contacts:
Karen Tiao, Head of IR/PR
Himax Technologies, Inc.
Tel: +886-2-2370-3999
Fax: +886-2-2314-0877
Email: hx_ir@himax.com.tw
www.himax.com.tw
Mark Schwalenberg, Director
Investor Relations - US Representative
MZ North America
Tel: +1-312-261-6430
Email: HIMX@mzgroup.us
www.mzgroup.us
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a129e586-9c5f-4f5f-998a-e831ea57972e
